HCP Website for Weekly Growth Hormone Injections

Sogroya® was the first once-weekly human growth hormone approved for children and adults with growth hormone deficiency (GHD). As lead writer for sogroyapro.com, I crafted content that gave healthcare professionals a clear, confident way to navigate clinical data, dosing, and patient support.

2024 MM+M GOLD
Branded Website for Healthcare Professionals

My work included shaping narratives around efficacy and safety, dosing guidance, and device education—highlighting the ease and flexibility of the Sogroya® Pen. The goal was to make complex study results and product features feel straightforward and actionable, so clinicians could quickly find what they needed. Just as important, I aimed to reflect the real-world challenges of treating children and adults with GHD, ensuring the site felt both scientifically precise and practically useful.